Deconstructing myths,building alliances: a networking model to enhance tobacco control in hospital mental health settings

Life expectancy for people with severe mental disorders is up to 25 years less in comparison to the general population, mainly due to diseases caused or worsened by smoking. However, smoking is usually a neglected issue in mental healthcare settings. The aim of this article is to describe a strategy to improve tobacco control in the hospital mental healthcare services of Catalonia (Spain). To bridge this gap, the Catalan Network of Smoke-free Hospitals launched a nationwide bottom-up strategy in Catalonia in 2007. The strategy relied on the creation of a working group of key professionals from various hospitals —the early adopters— based on Rogers’ theory of the Diffusion of Innovations. In 2016, the working group is composed of professionals from 17 hospitals (70.8% of all hospitals in the region with mental health inpatient units). Since 2007, tobacco control has improved in different areas such as increasing mental health professionals’ awareness of smoking, training professionals on smoking cessation interventions and achieving good compliance with the national smoking ban. The working group has produced and disseminated various materials, including clinical practice and best practice guidelines, implemented smoking cessation programmes and organised seminars and training sessions on smoking cessation measures in patients with mental illnesses. The next challenge is to ensure effective follow-up for smoking cessation after discharge. While some areas of tobacco control within these services still require significant improvement, the aforementioned initiative promotes successful tobacco control in these settings.     

根深叶茂花自开——中国小儿骨科的起源和发展

我国小儿骨科源起于20世纪50年代,中华人民共和国成立后,曾经在欧美国家接受过现代骨科学教育的中国骨科奠基人孟继懋、叶衍庆、方先之等学者们先后在北京、上海、天津等大城市组建了骨科为主的医院或研究所:北京积水潭医院、上海瑞金医院伤骨科研究所、天津骨科医院等,专门诊治骨科患者并进行教学和科研培训,早期主要治疗骨髓炎、骨结核、骨折等疾病[1]。1954 年天津骨科医院成立了专门的小儿骨科,是国内最早成立的独立建制的科室。     

Sequence-dependent Termination of Mammalian DNA Polymerase Reaction by a New Platinum Compound, (–)-(R)-2-Aminomethylpyrrolidine(1,1-cyclobutane-dicarboxylato)-2-platinum(II) Monohydrate

We examined the mechanisms of the inhibition of DNA synthesis by a new platinum compound, (-)-( R )-2-aminomethylpyrrolidine(1,1-cyclobutane-dicarboxylato)-2-platinum(II) monohydrate (DWA-2114R), a derivative of the antitumor drug cis- diamminedichloroplatinum(II) (CDDP), using prokaryotic and eukaryotic DNA polymerases. Preincubating activated DNA with CDDP or DWA-2114R reduced its template activity for prokaryotic and eukaryotic DNA polymerases in a dose-dependent manner. DWA2114R required six times greater drug concentration and two times longer incubation time to show the same decrease of the template activity compared to CDDP. Treatment of primed pUC118 ssDNA templates with the two drugs followed by second-strand synthesis by prokaryotic and eukaryotic DNA polymerases revealed that DWA2114R bound to DNA in a similar manner to CDDP and these adducts blocked DNA elongation by DNA polymerases of eukaryotes as well as of prokaryotes. With these two drugs, the elongations by E. coli DNA polymerase I (Klenow fragment), T7 DNA polymerase and calf thymus DNA polymerase α were strongly arrested at guanine-guanine sequences (GG). Stop bands were also observed at adenine-guanine sequences (AG) guanine-adenine-guanine sequences (GAG) and mono-guanine sequence (G). Calf testis DNA polymerase β was also arrested efficiently at AG, GAG and G, but much more weakly at GG. This pattern was common to DWA2114R and CDDP.     

Pin1和周期素D1在胰腺癌中的表达及其意义

目的:检测胰腺癌及癌旁组织中Pin1和周期素D1基因的表达,探讨Pin1在胰腺癌发病中所起的作用。方法:收集27例胰腺肿瘤组织及其相应的肿瘤旁组织标本,采用实时荧光定量逆转录聚合酶链反应法（RQ RT-PCR）检测胰腺良恶性肿瘤及肿瘤旁组织中Pin1和周期素D1 mRNA 的表达,运用Fisher精确概率分析两者之间的相关性及其与肿瘤临床分期和病理特征的关系。结果:7例胰腺囊腺瘤中周期素D1和Pin1的表达与肿瘤旁组织之间无显著性差异;而20例胰腺癌中周期素D1和Pin1的表达明显高于肿瘤旁组织［（2.78±1.02）vs.（4.36±1.27）和(5.48±1.69) vs. (9.97±1.86),P<0.05）］。Pin1和周期素D1与肿瘤的临床分期和病理分化程度无明显的相关（组间差异均为P>0.05）,但Pin1与周期素D1的表达有关（P<0.01）。 结论:胰腺癌中Pin1的过表达可促进周期素D1表达,由此诱导了肿瘤的发生;Pin1可能在胰腺癌中起着重要作用。     

多重PCR归化法平行检测HBV和HCV的研究

目的：建立一种多重PCR归化法并应用于对HBV、HCV平行检测。方法：利用PCR反应5′端允许添加非互补序列的原理，运用内外两对引物，经过2轮扩增，使目的产物均带上共有序列，再以共有序列为引物进行扩增，实现多重扩增。比较和筛选四种核酸提取方法。运用正交优化法，优化并确定最佳扩增条件。对28份血标本进行对比试验，并进行质量评价。结果：归化多重PCR方法对于HBV、HCV病毒合并感染患者的诊断敏感性为83.5%，诊断特异性为70.0%，诊断指数为153．3％，诊断效率为72．2％；对HBsAg阳性患者的HBV DNA的诊断敏感性为78．6％，诊断特异性为80．0％，诊断指数为158．6％，诊断效率为79．2％。对抗－HCV阳性患者的HCV RNA的诊断敏感性为75．0％，诊断特异性为90．0％，诊断指数为165．0％，诊断效率为83．3％。结论：多重PCR归化法在多基因扩增或多种病原体的同时平行检测领域具有较大应用潜力。该方法实用、准确、可靠，对HBV HCV的防治具有实际意义。     

狗喉上神经袢神经束性质的鉴别

用成年杂种狗１２只，在全麻状态下放血，取其颈交感干与喉上神经外支间的交通支及其与喉上神经外支汇合后的神经干，甲醛固定，明胶包埋，恒冷切片后用Ｋａｒｎｏｖｓｋｙ乙酰胆碱酯酶组化方法，对上述材料进行观察。我们发现交通支多为无髓纤维，酶反应呈强阳；混合后的神经含有髓酶反应阳性和阴性纤维及无髓酶反应强阳性纤维，证实喉上神经袢含有体躯运动、内脏运动（交感神经）纤维及感觉纤维。因此，喉上神经拌为混合神经。     

氯沙坦通过下调单核细胞趋化蛋白1受体表达抑制单核细胞活化

目的探讨血管紧张素Ⅱ对单核细胞趋化蛋白1受体CCR2表达的影响及氯沙坦的干预作用。方法人单核细胞株与血管紧张素Ⅱ(10-7mol/L)孵育,加或不加氯沙坦(10-7、10-6和10-5mol/L),检测上清液中单核细胞趋化蛋白1水平、单核和内皮细胞粘附情况以及CCR2mRNA的表达。结果与对照组比较,血管紧张素Ⅱ明显增加单核细胞培养上清液中单核细胞趋化蛋白1水平(26.46±3.58ng/L比10.56±2.34ng/L,P<0.01),增加单核内皮细胞间粘附(596±27比268±16,P<0.01)。血管紧张素Ⅱ刺激细胞后明显上调CCR2mRNA表达,氯沙坦能显著抑制血管紧张素Ⅱ的作用,降低单核细胞趋化蛋白1的水平,减少单核内皮细胞间粘附,下调CCR2 mRNA表达。结论氯沙坦通过下调单核细胞趋化蛋白1受体CCR2基因表达抑制单核细胞活化。     

多聚酶链反应检测细菌DNA对大鼠空、回肠吻合口瘘的早期诊断价值

目的:探讨PCR检测大鼠外周血及腹水中细菌DNA对空肠-空肠、回肠-回肠吻合口瘘的早期诊断价值。方法:健康Wistar雌性大鼠50只，随机分成5组，每组10只：A组为假手术组;B组为空肠-空肠吻合组;C组为空肠吻合口瘘组;D组为回肠-回肠吻合组;E组为回肠吻合口瘘组。采集手术前后外周血及术后腹水，抽提DNA, 比较lacZ基因和16SrRNA基因的PCR阳性率，并观察各组的病理学情况。结果:（1）C，E组术后外周血lacZ基因PCR阳性率与B，D组无显著性差异（P>0.05）;C，E组术后外周血16SrRNA基因PCR阳性率显著高于B，D组（P<0.05）。（2）C，E组腹水lacZ基因和16SrRNA基因PCR阳性率均显著高于B，D组（P<0.05）。（3）C，E组腹水lacZ基因阳性率显著高于外周血（P<0.05）;C，E组腹水16SrRNA基因阳性率与外周血无显著性差异（P>0.05）。结论:（1）PCR检测术后外周血16SrRNA基因对空、回肠吻合口瘘的早期诊断有一定意义;（2）检测术后腹水lacZ基因和16SrRNA基因对空肠-空肠、回肠-回肠吻合口瘘的早期诊断也有一定意义。     

谷胱甘肽S转移酶M1基因缺失与喉癌易患性的相关性研究

目的 :建立聚合酶链反应 (PCR)方法检测谷胱甘肽 S转移酶 (GST) M1基因 ,并探讨 GST M1基因缺失 (无效基因型 )与喉癌易患性的相关性。方法 :观察组选择确诊的喉癌 4 2例 ,正常对照组 10 8例 ;取被检者外周静脉血白细胞 ,抽提制备脱氧核糖核苷酸 (DNA) ;选择优化后的 PCR反应体系和循环参数扩增 GSTM1,扩增后的基因产物用 2 %琼脂糖凝胶电泳 ,紫外线灯下观察并记录结果。结果 :(1)成功建立聚合酶链反应结合琼脂糖凝胶电泳技术检测 GSTM1基因的方法。(2 )喉癌组 GST M1基因缺失率 (71.4 % )明显高于正常对照组 (48.1% )显示两组之间差异存在显著性 (χ2 =6 .6 1,P<0 .0 5 )。结论 :(1)聚合酶链反应是一种简单敏感 ,准确可靠的分析 GST M1基因多态性的方法。 (2 )该地区 GST M1基因缺失与喉癌的易患性相关联     

医药团结合作 建设放心药房

总结了全国放心药店现场交流会后,全国各地放心药房建设的情况。强调了建设放心药房工作的意义,指出建设放心药房是中医医疗机构精神文明建设的重要部分,是落实中央指示,加强药品管理的具体行动,是加强中医医疗机构内涵建设的重要内容,是保证中医医疗质量的关键环节。对进一步做好放心药房建设工作提出了要求:规范进货行为,把好药品进货关;不断深化改革,加强内部管理;认真贯彻国家有关法规,继续整治药品回扣违法行为;加强医药团结合作,建立稳定的供需关系;加强领导,务求实效,使“放心药房”建设深入持久地开展下去。